Eli Lilly said it would raise drug prices in Europe to "make them lower" in U.S., though the actual impact on most patients ...

The latest obesity bet from Eli Lilly and Co. involves a Boston biotech based out of the pharma giant’s new Fort Point R&D ...

It comes as President Donald Trump pressures drugmakers to lower U.S. drug prices while hiking them abroad under a policy ...

Eli Lilly will increase the price of its weight loss and diabetes drug Mounjaro in the UK by up to 170% from September, ...

Texas Pacific Land Corporation ( TPL) shares rose after the owner of properties for oil and gas exploration announced it was ...

Eli Lilly is significantly increasing the UK list price of its weight-loss and diabetes drug, Mounjaro, by up to 170%. This ...

Eli Lilly has said it will raise the UK list price of its diabetes and obesity therapy Mounjaro for people who buy the drug ...

Eli Lilly is increasing Mounjaro's UK price by 170% to match European market levels, with the highest dose now costing £330.

Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop ...

Chinese authorities did not renew a conditional approval of Green Valley Pharmaceuticals’ controversial Alzheimer’s disease ...

The Boston-based AI/ML startup focuses on endocrine and cardiometabolic diseases and will use that expertise to generate new ...